 | • レポートコード：D0804-09293 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、腫瘍溶解性ウイルスの世界市場を広く調査・分析し、今後の市場展望をまとめております。腫瘍溶解性ウイルスの種類別市場規模（Imlygic、オンコリン、その他）、用途別市場規模（黒色腫、その他のがん）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Amgen、SillaJen Biotherapeutics、Transgene SA、Oncolytics Biotech、PsiOxus Therapeutics、Viralytics、Lokon Pharma、Targovax、Oncolys BioPharma、Sorrento Therapeutics、Genelux Corporation、Cold Genesys、Vyriad、TILT Biotherapeutics ・地域別グローバル市場分析 2015年-2020年 ・腫瘍溶解性ウイルスの北米市場（アメリカ、カナダ、メキシコ） ・腫瘍溶解性ウイルスのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・腫瘍溶解性ウイルスのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・腫瘍溶解性ウイルスの南米市場（ブラジル、アルゼンチン） ・腫瘍溶解性ウイルスの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：Imlygic、オンコリン、その他 ・用途別分析：黒色腫、その他のがん ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Oncolytic Virus market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Oncolytic Virus market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.5%% in the forecast period of 2020 to 2025 and will expected to reach USD 21 million by 2025, from USD 16 million in 2019.
Market segmentation
Oncolytic Virus market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oncolytic Virus market has been segmented into
Imlygic
Oncorine
Others
By Application, Oncolytic Virus has been segmented into:
Melanoma
Other Cancers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncolytic Virus market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncolytic Virus markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncolytic Virus market.
The report offers in-depth assessment of the growth and other aspects of the Oncolytic Virus market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Oncolytic Virus Market Share Analysis
Oncolytic Virus competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oncolytic Virus sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncolytic Virus sales, revenue and market share for each player covered in this report.
The major players covered in Oncolytic Virus are:
Amgen
SillaJen Biotherapeutics
Transgene SA
Oncolytics Biotech
PsiOxus Therapeutics
Viralytics
Lokon Pharma
Targovax
Oncolys BioPharma
Sorrento Therapeutics
Genelux Corporation
Cold Genesys
Vyriad
TILT Biotherapeutics
Among other players domestic and global, Oncolytic Virus market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oncolytic Virus product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oncolytic Virus, with price, sales, revenue and global market share of Oncolytic Virus in 2018 and 2019.
Chapter 3, the Oncolytic Virus competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncolytic Virus breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Oncolytic Virus market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Oncolytic Virus sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Oncolytic Virus Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oncolytic Virus Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Imlygic
1.2.3 Oncorine
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Oncolytic Virus Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Melanoma
1.3.3 Other Cancers
1.4 Overview of Global Oncolytic Virus Market
1.4.1 Global Oncolytic Virus Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 SillaJen Biotherapeutics
2.2.1 SillaJen Biotherapeutics Details
2.2.2 SillaJen Biotherapeutics Major Business
2.2.3 SillaJen Biotherapeutics SWOT Analysis
2.2.4 SillaJen Biotherapeutics Product and Services
2.2.5 SillaJen Biotherapeutics Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Transgene SA
2.3.1 Transgene SA Details
2.3.2 Transgene SA Major Business
2.3.3 Transgene SA SWOT Analysis
2.3.4 Transgene SA Product and Services
2.3.5 Transgene SA Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Oncolytics Biotech
2.4.1 Oncolytics Biotech Details
2.4.2 Oncolytics Biotech Major Business
2.4.3 Oncolytics Biotech SWOT Analysis
2.4.4 Oncolytics Biotech Product and Services
2.4.5 Oncolytics Biotech Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 PsiOxus Therapeutics
2.5.1 PsiOxus Therapeutics Details
2.5.2 PsiOxus Therapeutics Major Business
2.5.3 PsiOxus Therapeutics SWOT Analysis
2.5.4 PsiOxus Therapeutics Product and Services
2.5.5 PsiOxus Therapeutics Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Viralytics
2.6.1 Viralytics Details
2.6.2 Viralytics Major Business
2.6.3 Viralytics Product and Services
2.6.4 Viralytics Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Lokon Pharma
2.7.1 Lokon Pharma Details
2.7.2 Lokon Pharma Major Business
2.7.3 Lokon Pharma Product and Services
2.7.4 Lokon Pharma Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Targovax
2.8.1 Targovax Details
2.8.2 Targovax Major Business
2.8.3 Targovax Product and Services
2.8.4 Targovax Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Oncolys BioPharma
2.9.1 Oncolys BioPharma Details
2.9.2 Oncolys BioPharma Major Business
2.9.3 Oncolys BioPharma Product and Services
2.9.4 Oncolys BioPharma Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sorrento Therapeutics
2.10.1 Sorrento Therapeutics Details
2.10.2 Sorrento Therapeutics Major Business
2.10.3 Sorrento Therapeutics Product and Services
2.10.4 Sorrento Therapeutics Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Genelux Corporation
2.11.1 Genelux Corporation Details
2.11.2 Genelux Corporation Major Business
2.11.3 Genelux Corporation Product and Services
2.11.4 Genelux Corporation Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Cold Genesys
2.12.1 Cold Genesys Details
2.12.2 Cold Genesys Major Business
2.12.3 Cold Genesys Product and Services
2.12.4 Cold Genesys Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Vyriad
2.13.1 Vyriad Details
2.13.2 Vyriad Major Business
2.13.3 Vyriad Product and Services
2.13.4 Vyriad Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 TILT Biotherapeutics
2.14.1 TILT Biotherapeutics Details
2.14.2 TILT Biotherapeutics Major Business
2.14.3 TILT Biotherapeutics Product and Services
2.14.4 TILT Biotherapeutics Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Oncolytic Virus Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Oncolytic Virus Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Oncolytic Virus Manufacturer Market Share in 2019
3.3.2 Top 6 Oncolytic Virus Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Oncolytic Virus Sales, Revenue and Market Share by Regions
4.1.1 Global Oncolytic Virus Sales and Market Share by Regions (2015-2020)
4.1.2 Global Oncolytic Virus Revenue and Market Share by Regions (2015-2020)
4.2 North America Oncolytic Virus Sales and Growth Rate (2015-2020)
4.3 Europe Oncolytic Virus Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Oncolytic Virus Sales and Growth Rate (2015-2020)
4.5 South America Oncolytic Virus Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Oncolytic Virus Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Oncolytic Virus Sales, Revenue and Market Share by Country
5.1.1 North America Oncolytic Virus Sales and Market Share by Country (2015-2020)
5.1.2 North America Oncolytic Virus Revenue and Market Share by Country (2015-2020)
5.2 United States Oncolytic Virus Sales and Growth Rate (2015-2020)
5.3 Canada Oncolytic Virus Sales and Growth Rate (2015-2020)
5.4 Mexico Oncolytic Virus Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Oncolytic Virus Sales, Revenue and Market Share by Country
6.1.1 Europe Oncolytic Virus Sales and Market Share by Country (2015-2020)
6.1.2 Europe Oncolytic Virus Revenue and Market Share by Country (2015-2020)
6.2 Germany Oncolytic Virus Sales and Growth Rate (2015-2020)
6.3 UK Oncolytic Virus Sales and Growth Rate (2015-2020)
6.4 France Oncolytic Virus Sales and Growth Rate (2015-2020)
6.5 Russia Oncolytic Virus Sales and Growth Rate (2015-2020)
6.6 Italy Oncolytic Virus Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Oncolytic Virus Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Oncolytic Virus Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Oncolytic Virus Revenue and Market Share by Regions (2015-2020)
7.2 China Oncolytic Virus Sales and Growth Rate (2015-2020)
7.3 Japan Oncolytic Virus Sales and Growth Rate (2015-2020)
7.4 Korea Oncolytic Virus Sales and Growth Rate (2015-2020)
7.5 India Oncolytic Virus Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Oncolytic Virus Sales and Growth Rate (2015-2020)
7.7 Australia Oncolytic Virus Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Oncolytic Virus Sales, Revenue and Market Share by Country
8.1.1 South America Oncolytic Virus Sales and Market Share by Country (2015-2020)
8.1.2 South America Oncolytic Virus Revenue and Market Share by Country (2015-2020)
8.2 Brazil Oncolytic Virus Sales and Growth Rate (2015-2020)
8.3 Argentina Oncolytic Virus Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Oncolytic Virus Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Oncolytic Virus Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Oncolytic Virus Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Oncolytic Virus Sales and Growth Rate (2015-2020)
9.3 Turkey Oncolytic Virus Sales and Growth Rate (2015-2020)
9.4 Egypt Oncolytic Virus Sales and Growth Rate (2015-2020)
9.5 South Africa Oncolytic Virus Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Oncolytic Virus Sales and Market Share by Type (2015-2020)
10.2 Global Oncolytic Virus Revenue and Market Share by Type (2015-2020)
10.3 Global Oncolytic Virus Price by Type (2015-2020)
11 Global Oncolytic Virus Market Segment by Application
11.1 Global Oncolytic Virus Sales Market Share by Application (2015-2020)
11.2 Global Oncolytic Virus Revenue Market Share by Application (2015-2020)
11.3 Global Oncolytic Virus Price by Application (2015-2020)
12 Market Forecast
12.1 Global Oncolytic Virus Sales, Revenue and Growth Rate (2021-2025)
12.2 Oncolytic Virus Market Forecast by Regions (2021-2025)
12.2.1 North America Oncolytic Virus Market Forecast (2021-2025)
12.2.2 Europe Oncolytic Virus Market Forecast (2021-2025)
12.2.3 Asia-Pacific Oncolytic Virus Market Forecast (2021-2025)
12.2.4 South America Oncolytic Virus Market Forecast (2021-2025)
12.2.5 Middle East & Africa Oncolytic Virus Market Forecast (2021-2025)
12.3 Oncolytic Virus Market Forecast by Type (2021-2025)
12.3.1 Global Oncolytic Virus Sales Forecast by Type (2021-2025)
12.3.2 Global Oncolytic Virus Market Share Forecast by Type (2021-2025)
12.4 Oncolytic Virus Market Forecast by Application (2021-2025)
12.4.1 Global Oncolytic Virus Sales Forecast by Application (2021-2025)
12.4.2 Global Oncolytic Virus Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Oncolytic Virus Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oncolytic Virus by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oncolytic Virus Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Oncolytic Virus Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Oncolytic Virus Major Business
Table 10. Amgen Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 11. Amgen SWOT Analysis
Table 12. Amgen Oncolytic Virus Product and Services
Table 13. Amgen Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. SillaJen Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 15. SillaJen Biotherapeutics Oncolytic Virus Major Business
Table 16. SillaJen Biotherapeutics Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 17. SillaJen Biotherapeutics SWOT Analysis
Table 18. SillaJen Biotherapeutics Oncolytic Virus Product and Services
Table 19. SillaJen Biotherapeutics Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Transgene SA Basic Information, Manufacturing Base and Competitors
Table 21. Transgene SA Oncolytic Virus Major Business
Table 22. Transgene SA Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 23. Transgene SA SWOT Analysis
Table 24. Transgene SA Oncolytic Virus Product and Services
Table 25. Transgene SA Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Oncolytics Biotech Basic Information, Manufacturing Base and Competitors
Table 27. Oncolytics Biotech Oncolytic Virus Major Business
Table 28. Oncolytics Biotech Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 29. Oncolytics Biotech SWOT Analysis
Table 30. Oncolytics Biotech Oncolytic Virus Product and Services
Table 31. Oncolytics Biotech Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. PsiOxus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 33. PsiOxus Therapeutics Oncolytic Virus Major Business
Table 34. PsiOxus Therapeutics Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 35. PsiOxus Therapeutics SWOT Analysis
Table 36. PsiOxus Therapeutics Oncolytic Virus Product and Services
Table 37. PsiOxus Therapeutics Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Viralytics Basic Information, Manufacturing Base and Competitors
Table 39. Viralytics Oncolytic Virus Major Business
Table 40. Viralytics Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 41. Viralytics SWOT Analysis
Table 42. Viralytics Oncolytic Virus Product and Services
Table 43. Viralytics Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Lokon Pharma Basic Information, Manufacturing Base and Competitors
Table 45. Lokon Pharma Oncolytic Virus Major Business
Table 46. Lokon Pharma Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 47. Lokon Pharma SWOT Analysis
Table 48. Lokon Pharma Oncolytic Virus Product and Services
Table 49. Lokon Pharma Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Targovax Basic Information, Manufacturing Base and Competitors
Table 51. Targovax Oncolytic Virus Major Business
Table 52. Targovax Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 53. Targovax SWOT Analysis
Table 54. Targovax Oncolytic Virus Product and Services
Table 55. Targovax Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Oncolys BioPharma Basic Information, Manufacturing Base and Competitors
Table 57. Oncolys BioPharma Oncolytic Virus Major Business
Table 58. Oncolys BioPharma Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 59. Oncolys BioPharma SWOT Analysis
Table 60. Oncolys BioPharma Oncolytic Virus Product and Services
Table 61. Oncolys BioPharma Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Sorrento Therapeutics Basic Information, Manufacturing Base and Competitors
Table 63. Sorrento Therapeutics Oncolytic Virus Major Business
Table 64. Sorrento Therapeutics Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 65. Sorrento Therapeutics SWOT Analysis
Table 66. Sorrento Therapeutics Oncolytic Virus Product and Services
Table 67. Sorrento Therapeutics Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Genelux Corporation Basic Information, Manufacturing Base and Competitors
Table 69. Genelux Corporation Oncolytic Virus Major Business
Table 70. Genelux Corporation Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 71. Genelux Corporation SWOT Analysis
Table 72. Genelux Corporation Oncolytic Virus Product and Services
Table 73. Genelux Corporation Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Cold Genesys Basic Information, Manufacturing Base and Competitors
Table 75. Cold Genesys Oncolytic Virus Major Business
Table 76. Cold Genesys Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 77. Cold Genesys SWOT Analysis
Table 78. Cold Genesys Oncolytic Virus Product and Services
Table 79. Cold Genesys Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Vyriad Basic Information, Manufacturing Base and Competitors
Table 81. Vyriad Oncolytic Virus Major Business
Table 82. Vyriad Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 83. Vyriad SWOT Analysis
Table 84. Vyriad Oncolytic Virus Product and Services
Table 85. Vyriad Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. TILT Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 87. TILT Biotherapeutics Oncolytic Virus Major Business
Table 88. TILT Biotherapeutics Oncolytic Virus Total Revenue (USD Million) (2018-2019)
Table 89. TILT Biotherapeutics SWOT Analysis
Table 90. TILT Biotherapeutics Oncolytic Virus Product and Services
Table 91. TILT Biotherapeutics Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Global Oncolytic Virus Sales by Manufacturer (2018-2019) (K Units)
Table 93. Global Oncolytic Virus Revenue by Manufacturer (2018-2019) (USD Million)
Table 94. Global Oncolytic Virus Sales by Regions (2015-2020) (K Units)
Table 95. Global Oncolytic Virus Sales Market Share by Regions (2015-2020)
Table 96. Global Oncolytic Virus Revenue by Regions (2015-2020) (USD Million)
Table 97. North America Oncolytic Virus Sales by Countries (2015-2020) (K Units)
Table 98. North America Oncolytic Virus Sales Market Share by Countries (2015-2020)
Table 99. North America Oncolytic Virus Revenue by Countries (2015-2020) (USD Million)
Table 100. North America Oncolytic Virus Revenue Market Share by Countries (2015-2020)
Table 101. Europe Oncolytic Virus Sales by Countries (2015-2020) (K Units)
Table 102. Europe Oncolytic Virus Sales Market Share by Countries (2015-2020)
Table 103. Europe Oncolytic Virus Revenue by Countries (2015-2020) (USD Million)
Table 104. Asia-Pacific Oncolytic Virus Sales by Regions (2015-2020) (K Units)
Table 105. Asia-Pacific Oncolytic Virus Sales Market Share by Regions (2015-2020)
Table 106. Asia-Pacific Oncolytic Virus Revenue by Regions (2015-2020) (USD Million)
Table 107. South America Oncolytic Virus Sales by Countries (2015-2020) (K Units)
Table 108. South America Oncolytic Virus Sales Market Share by Countries (2015-2020)
Table 109. South America Oncolytic Virus Revenue by Countries (2015-2020) (USD Million)
Table 110. South America Oncolytic Virus Revenue Market Share by Countries (2015-2020)
Table 111. Middle East & Africa Oncolytic Virus Sales by Countries (2015-2020) (K Units)
Table 112. Middle East & Africa Oncolytic Virus Sales Market Share by Countries (2015-2020)
Table 113. Middle East & Africa Oncolytic Virus Revenue by Countries (2015-2020) (USD Million)
Table 114. Middle East & Africa Oncolytic Virus Revenue Market Share by Countries (2015-2020)
Table 115. Global Oncolytic Virus Sales by Type (2015-2020) (K Units)
Table 116. Global Oncolytic Virus Sales Share by Type (2015-2020)
Table 117. Global Oncolytic Virus Revenue by Type (2015-2020) (USD Million)
Table 118. Global Oncolytic Virus Revenue Share by Type (2015-2020)
Table 119. Global Oncolytic Virus Sales by Application (2015-2020) (K Units)
Table 120. Global Oncolytic Virus Sales Share by Application (2015-2020)
Table 121. Global Oncolytic Virus Sales Forecast by Regions (2021-2025) (K Units)
Table 122. Global Oncolytic Virus Market Share Forecast by Regions (2021-2025)
Table 123. Global Oncolytic Virus Sales Forecast by Type (2021-2025) (K Units)
Table 124. Global Oncolytic Virus Market Share Forecast by Type (2021-2025)
Table 125. Global Oncolytic Virus Sales Forecast by Application (2021-2025)
Table 126. Global Oncolytic Virus Market Share Forecast by Application (2021-2025)
Table 127. Direct Channel Pros & Cons
Table 128. Indirect Channel Pros & Cons
Table 129. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Oncolytic Virus Picture
Figure 2. Global Sales Market Share of Oncolytic Virus by Type in 2019
Figure 3. Imlygic Picture
Figure 4. Oncorine Picture
Figure 5. Others Picture
Figure 6. Oncolytic Virus Sales Market Share by Application in 2019
Figure 7. Melanoma Picture
Figure 8. Other Cancers Picture
Figure 9. Global Oncolytic Virus Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Oncolytic Virus Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Oncolytic Virus Sales Market Share by Manufacturer in 2019
Figure 30. Global Oncolytic Virus Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Oncolytic Virus Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Oncolytic Virus Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Oncolytic Virus Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Oncolytic Virus Revenue Market Share by Regions (2015-2020)
Figure 37. Global Oncolytic Virus Revenue Market Share by Regions in 2018
Figure 38. North America Oncolytic Virus Sales and Growth Rate (2015-2020)
Figure 39. Europe Oncolytic Virus Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Oncolytic Virus Sales and Growth Rate (2015-2020)
Figure 41. South America Oncolytic Virus Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Oncolytic Virus Sales and Growth Rate (2015-2020)
Figure 43. North America Oncolytic Virus Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Oncolytic Virus Sales Market Share by Countries (2015-2020)
Figure 45. North America Oncolytic Virus Sales Market Share by Countries in 2018
Figure 46. North America Oncolytic Virus Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Oncolytic Virus Revenue Market Share by Countries in 2018
Figure 48. United States Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Oncolytic Virus Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Oncolytic Virus Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Oncolytic Virus Revenue Market Share by Countries in 2019
Figure 54. Germany Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Oncolytic Virus Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Oncolytic Virus Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Oncolytic Virus Revenue Market Share by Regions 2019
Figure 62. China Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Oncolytic Virus Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Oncolytic Virus Sales Market Share by Countries in 2019
Figure 69. South America Oncolytic Virus Revenue Market Share by Countries in 2019
Figure 70. Brazil Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Oncolytic Virus Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Oncolytic Virus Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Oncolytic Virus Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Oncolytic Virus Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Oncolytic Virus Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Oncolytic Virus Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Oncolytic Virus Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Oncolytic Virus Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Oncolytic Virus Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Oncolytic Virus Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Oncolytic Virus Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Oncolytic Virus Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
腫瘍溶解性ウイルス療法の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Oncolytic Virus Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…- 腫瘍溶解性ウイルスがん免疫療法の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Oncolytic Virus Cancer Immunotherapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oncolyti…
- 呼吸器合胞体ウイルス（RSV）診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Respiratory Syncytial Virus (RSV) Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…
- ウイルス検査診断キットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Virus Testing Diagnostic Kits market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Virus Testing D…
- 抗肝炎ウイルス薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti Hepatitis Virus Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…